Jonathan Young is the founder of Akero Therapeutics. Akero Therapeutics has raised $65M in total funding. Latest round: Series A.
Jonathan Young is the Co-Founder and Chief Operating Officer (COO) of Akero Therapeutics, a biotechnology company focused on treating non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. He successfully raised $65 million in Series A financing for the company.
Full founder directory · Investor directory · Company funding database · Fundraising library